Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 1, 2010, Pages 62-67

  Hu, Xiaolan ^a   Zhang, Xianqi ^b   Qiu, Shuifeng ^a   Yu, Daihua ^c   Lin, Shuxin ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer cells; Cell apoptosis; Cell proliferation; Salidroside

Indexed keywords

ESTROGEN RECEPTOR; SALIDROSIDE; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GLUCOSIDES; HUMANS; PHENOLS;

RHODIOLA;

EID: 77954756984     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.033     Document Type: Article

References (27)

1. Nandi S., Guzman R.C., Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA 1995, 92:3650-3657.
2. Saji S., Kuroi K. Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature. Breast Cancer 2008, 15:262-269.
3. Cline J.M., Hughes C.L. Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treat. Res. 1998, 94:107-134.
4. Einbond L.S., Shimizu M., Ma H., Wu H.A., Goldsberry S., Sicular S., Panjikaran M., Genovese G., Cruz E. Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem. Biophys. Res. Commun. 2008, 375:608-613.
5. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2003, 2:65-72.
6. Mai Z., Blackburn G.L., Zhou J.R. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis 2007, 28:1217-1223.
7. Udintsev S.N., Shakhov V.P. The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma 1991, 38:323-331.
8. Ming D.S., Hillhouse B.J., Guns E.S., Eberding A., Xie S., Vimalanathan S., Towers G.H. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother. Res. 2005, 19:740-743.
9. Kormosh N., Laktionov K., Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother. Res. 2006, 20:424-425.
10. Nagini S. Cancer chemoprevention by garlic and its organosulfur compounds - panacea or promise?. Anticancer Agents Med. Chem. 2008, 8:313-321.
11. Zhou X., Wu Y., Wang X., Liu B., Xu H. Salidroside production by hairy roots of Rhodiola sachalinensis obtained after transformation with Agrobacterium rhizogenes. Biol. Pharm. Bull. 2007, 30:439-442.
12. Chen X., Liu J., Gu X., Ding F. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats. Brain Res. 2008, 1238:189-198.
13. Wu T., Zhou H., Jin Z., Bi S., Yang X., Yi D., Liu W. Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur. J. Pharmacol. 2009, 613:93-99.
14. Wang H., Ding Y., Zhou J., Sun X., Wang S. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine 2009, 16:146-155.
15. Skopińska-Rózewska E., Malinowski M., Wasiutyński A., Sommer E., Furmanowa M., Mazurkiewicz M., Siwicki A.K. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol. J. Vet. Sci. 2008, 11:97-104.
16. X. Hu, S. Lin, D. Yu, S. Qiu, X. Zhang, R. Mei, A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines, Cell Biol. Toxicol. 2010 (Epub ahead of print).
17. Ward H.W. Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels. Br. Med. J. 1973, 1:13-14.
18. Jordan V.C. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br. J. Pharmacol. 2006, 147:S269-S276.
19. Chu I., Blackwell K., Chen S., Slingerland J. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expressions in antiestrogen-resistant breast cancer. Cancer Res. 2005, 65:18-25.
20. Wu K., DuPré E., Kim H., Tin-U C.K., Bissonnette R.P., Lamph W.W., Brown P.H. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade. Breast Cancer Res. Treat. 2006, 96:147-157.
21. Ang E.Z., Nguyen H.T., Sim H.L., Putti T.C., Lim L.H. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol. Cancer Res. 2009, 7:266-274.
22. Coqueret O. Linking cyclins to transcriptional control. Gene 2002, 299:35-55.
23. Popov B., Chang L.S., Serikov V. Cell cycle-related transformation of the E2F4-p130 repressor complex. Biochem. Biophys. Res. Commun. 2005, 336:762-769.
24. Besson A., Dowdy S.F., Roberts J.M. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell. 2008, 14:159-169.
25. Roninson I.B., Broude E.V., Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 2001, 4:303-313.
26. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995, 184:39-51.
27. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.